Changes in plasma renin concentration, activity and substrate after twentyeight days' treatment with micronized estrogen, ethinylestradiol and norethisterone-acetate in postmenopausal women.
D000328:Adult; D000808:Angiotensinogen / Q000097:blood*; D000809:Angiotensins / Q000097:blood*; D004967:Estrogens / Q000494:pharmacology* / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D009640:Norethindrone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000077563:Norethindrone Acetate; D011863:Radioimmunoassay; D012083:Renin / Q000097:blood*
D000809:Angiotensins; D004967:Estrogens; D000808:Angiotensinogen; D004997:Ethinyl Estradiol; D000077563:Norethindrone Acetate; D012083:Renin; D009640:Norethindrone